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The Journal of Immunology
Tissue- and Ligand-Specific Sensing of Gram-Negative
Infection in Drosophila by PGRP-LC Isoforms and PGRP-LE
Claudine Neyen,* Mickae¨l Poidevin,† Alain Roussel,‡ and Bruno Lemaitre*
The Drosophila antimicrobial response is one of the best characterized systems of pattern recognition receptor-mediated defense
in metazoans. Drosophila senses Gram-negative bacteria via two peptidoglycan recognition proteins (PGRPs), membrane-bound
PGRP-LC and secreted/cytosolic PGRP-LE, which relay diaminopimelic acid (DAP)-type peptidoglycan sensing to the Imd
signaling pathway. In the case of PGRP-LC, differential splicing of PGRP domain-encoding exons to a common intracellular
domain-encoding exon generates three receptor isoforms, which differ in their peptidoglycan binding specificities. In this study, we
used Phi31-mediated recombineering to generate fly lines expressing specific isoforms of PGRP-LC and assessed the tissue-specific
roles of PGRP-LC isoforms and PGRP-LE in the antibacterial response. Our in vivo studies demonstrate the key role of PGRP-
LCx in sensing DAP-type peptidoglycan-containing Gram-negative bacteria or Gram-positive bacilli during systemic infection.
We also highlight the contribution of PGRP-LCa/x heterodimers to the systemic immune response to Gram-negative bacteria
through sensing of tracheal cytotoxin (TCT), whereas PGRP-LCy may have a minor role in antagonizing the immune response.
Our results reveal that both PGRP-LC and PGRP-LE contribute to the intestinal immune response, with a predominant role of
cytosolic PGRP-LE in the midgut, the central section of endodermal origin where PGRP-LE is enriched. Our in vivo model also
definitively establishes TCT as the long-distance elicitor of systemic immune responses to intestinal bacteria observed in a loss-of-
tolerance model. In conclusion, our study delineates how a combination of extracellular sensing by PGRP-LC isoforms and
intracellular sensing through PGRP-LE provides sophisticated mechanisms to detect and differentiate between infections by
different DAP-type bacteria in Drosophila. The Journal of Immunology, 2012, 189: 1886–1897.
I
n animals, the innate immune system detects bacterial in-
fection through the use of germline-encoded pattern rec-
ognition receptors (PRRs) that sense pathogen-associated
molecular patterns (PAMPs), such as LPS, peptidoglycan, or fla-
gellin (1). After the identification of PRRs and their respective
ligands, a challenge in the field is to understand how each of these
various PRRs contributes to an effective and adapted immune
response. The study of innate immune recognition is complicated
by the existence of multiple PRRs with various expression pat-
terns, variation in PAMP exposure, and modifications through the
action of host and bacterial enzymes during the course of infection
(2). In addition, PAMP signals intersect with a less well under-
stood but equally complex network of endogenous danger signals,
which allow the immune system to discriminate between patho-
genic and non-pathogenic microorganisms (3). A better under-
standing of the mode of action of PRRs ideally requires an in vivo
approach in whole organisms using natural routes of infection.
The Drosophila antimicrobial response is one of the best char-
acterized systems of PRR-mediated defense in metazoans and
provides a good model to understand both the logic of pattern
recognition and how PRRs shape the ensuing immune response. In
this study, we use Phi31-mediated recombineering to generate fly
lines expressing specific isoforms of peptidoglycan recognition
protein (PGRP)-LC, a Drosophila PRR involved in sensing Gram-
negative bacteria.
Pattern recognition upstream of the two Drosophila innate
immune response branches, the Toll and Imd pathways, relies to
a large extent on peptidoglycan sensing by PGRPs (4). Peptido-
glycan, a cell wall component found in almost all bacteria, is a
polymer of alternating N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc), cross-linked by short peptide
bridges whose amino acid composition and organization differs
among bacteria. As evidenced by Gram staining, peptidoglycan
(PGN) forms an abundant external layer in Gram-positive bacteria
but is less abundant in Gram-negative bacteria where it is hidden
under an external layer of LPS. The structure of PGN from Ba-
cillus and Gram-negative bacteria differs from that of most Gram-
positive PGN in the third amino acid position of the peptide
bridge. Gram-negative and Bacillus-type PGNs are cross-linked
by a peptide containing a meso-diaminopimelic residue, whereas
in other Gram-positive bacterial PGNs a lysine is found in this
position (5). In addition, diaminopimelic acid (DAP)-type PGN
from Gram-negative bacteria but not DAP-type bacilli contains
anhydro-MurNAc residues at the end of each PGN strand, which
are distinctive footprints of bacterial PGN synthetic enzymes.
Monomers of GlcNAc-1,6-anhydro-MurNAc-L-Ala-g-D-Glu-meso-
DAP-D-Ala, also called tracheal cytotoxin (TCT), represent ∼5% of
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GlcNAc–MurNAc residues and were previously shown to be the
minimal PGN motif to elicit Imd responses in flies (6, 7). As
anhydro-muropeptides are released during bacterial cell wall
synthesis, TCT has been put forward as a specific indicator of
potentially dangerous Gram-negative bacterial proliferation (7–9).
Use of highly purified products has demonstrated that in con-
trast to vertebrates, sensing of Gram-negative bacteria in Droso-
phila is not based on recognition of LPS (6, 10). Rather, the ability
of Drosophila to discriminate between Gram-positive and Gram-
negative bacteria relies on the recognition of specific forms of
PGN by PGRPs. The Drosophila genome carries a total number of
13 PGRP genes, which give rise to 19 known different receptors
(11, 12). The family comprises both enzymatically active, generally
secreted, amidase PGRPs that cleave PGN into non-immunogenic
fragments and catalytically inactive receptors, generally membrane-
bound, which mediate ligand-dependent downstream signaling
(13). All family members contain at least one PGRP domain,
which is structurally related to bacterial T7 lysozymes and rec-
ognizes different types of PGN (11). Whereas PGRP-SA upstream
of Toll recognizes mainly lysine-containing PGN from Gram-
positive bacteria, Imd-activating PGRP-LC and PGRP-LE exclu-
sively sense DAP-type PGN from Gram-negative bacteria and
Gram-positive bacilli (10). In the case of PGRP-LC, differential
splicing of PGRP domain-encoding exons to a common intracel-
lular domain-encoding exon generates three receptor isoforms,
which differ in their PGN binding specificities but share identical
signaling capacities (6, 14). PGRP-LF, a highly similar but
signaling-deficient receptor encoded by the locus adjacent to
PGRP-LC, contains two functional PGRP domains but lacks the
intracellular signaling domain and acts as a negative regulator
of Imd activation (15, 16). Crystal structures of ligand-binding
domains of PGRP-LC isoforms in the presence of monomeric
PGN have defined the molecular basis for ligand binding. Only
PGRP-LCx contains the characteristic L-shaped PGN binding
groove described for mammalian PGRP-Ia (17) and Drosophila
PGRP-LB (18) and can accommodate polymeric and monomeric
PGN. Protruding residues in the ligand binding pocket of PGRP-
LCa prevent direct binding of TCT (19, 20), but PGRP-LCa
dimerizes with PGRP-LCx–TCT complexes via its PGN binding
groove (20, 21). Notably, PGRP domain affinity studies have de-
termined equivalent binding constants for PGRP-LCa and PGRP-
LF to PGRP-LCx–TCT complexes (22). Because activation of the
Imd pathway relies on ligand-induced receptor homo- or hetero-
multimerization, this implies that the stoichiometry of signaling-
efficient PGRP-LC isoforms to the signaling-deficient PGRP-LF
determines the strength of pathway activation.
Studies in cell culture using RNA interference (RNAi) specific
for each PGRP-LC isoform have shown that PGRP-LCx is re-
quired for recognition of polymeric PGN, whereas both PGRP-
LCa and PGRP-LCx are mandatory for detection of monomeric
PGN (6, 14). It has been proposed that signaling is achieved by
association of at least two PGRP-LCx molecules in close prox-
imity through binding of polymeric PGN (23). Such an interaction
cannot occur with monomeric PGN, and in this case PGRP-LCa
is expected to act as an adapter (21). This model is supported by
the crystallization of TCT in complex with both PGRP-LCa and
PGRP-LCx (20).
Although loss-of-function mutants established the fundamental
role of PGRP-LC in survival to Gram-negative infection (24–26),
the residual antimicrobial peptide response in flies lacking PGRP-
LC compared with Imd-deficient flies suggested a second receptor
upstream of Imd. PGRP-LE encodes a PGRP with affinity to DAP-
type PGN and is expressed both extracellularly and intracellularly
(27, 28). A secreted fragment of PGRP-LE corresponding to the
PGRP domain alone functions extracellularly to enhance PGRP-
LC–mediated PGN recognition on the cell surface, a role evoca-
tive of that of mammalian CD14 in binding of LPS to TLR4 (29).
The full-length form of PGRP-LE is cytoplasmic and acts as an
intracellular receptor for monomeric PGN, effectively bypassing
the requirement for PGRP-LC (29). Thus, both PGRP-LC and
PGRP-LE account for sensing of Gram-negative bacteria upstream
of the Imd pathway. Finally, detection of DAP-type PGN in
Drosophila is modulated by amidase PGRPs, which enzymatically
degrade PGN and reduce the amount of available immunostimu-
latory compounds (30, 31). Among these, PGRP-LB has been best
characterized as a negative regulator of the Imd pathway (9).
Despite a wealth of studies, several questions remain to be
addressed, including the respective contribution of each PGRP-LC
isoform and PGRP-LE in response to bacteria as well as the dif-
ferential requirement of these PRRs in specific tissues, especially in
barrier epithelia such as the gut that are constantly exposed to
bacterial stimuli. Overexpression studies using full-length and
ectodomain-truncated receptors lead to ligand-independent acti-
vation of the immune response, probably due to increased receptor
proximity in the membrane (23). It is therefore crucial to use an
in vivo model with wild-type receptor levels to interpret correctly
the mechanism of ligand-specific Imd activation downstream of
various PGRP-LC isoforms. We therefore used a genomic comple-
mentation approach to supplement PGRP-LC–deficient mutants
with isoform-specific PGRP-LC loci elsewhere in the genome.
This approach allowed us to generate wild-type levels of defined
PGRP-LC isoforms in vivo and to assess the tissue-specific roles of
each isoform, alone or in various combinations. Our results con-
firm previously described roles of PGRP-LCx and PGRP-LCa/x
dimers in polymeric and monomeric PGN sensing, respectively,
and uncover a new role for PGRP-LE in the activation of the Imd
pathway in the gut. In addition, our in vivo model definitively
establishes TCT as the long-distance elicitor of systemic immune
responses to intestinal bacteria observed in a case of rupture of
tolerance induced by knockdown of amidase PGRP-LB (9).
Materials and Methods
Fly stocks and generation of complementation lines
CantonS (CanS) and y,w flies were used as wild-type controls. The PGRP-
LCE12, PGRP-LCird7(1), PGRP-LBD, PGRP-LE112, and imd1 lines have
been described previously (24, 25, 28, 30, 32). PGRP-LC rescue lines were
generated using gap-repair and recombineering, and final rescue constructs
carried by P[acman] vectors were inserted into the PhiC31 landing site 51C
on chromosome 2 (BDSC strain 24482) (33, 34). Vectors with PGRP-LC
only contain the following sequence elements (based on FlyBase release
r5.42): [LC] 3L:9330982-9342747; [LCa] 3L:9330982-9338224;9340740-
9342747 (from sequence start until end of exon 7, then from beginning
of exon 14 until sequence end); [LCx] 3L:9330982-9338167;9338709-
9339359;931277-9342747 (from sequence start until end of exon 6, then
from beginning of exon 8 until 27 bp from end of 39UTR of exon 9, then
from beginning of 39UTR of exon 14 until sequence end); [LCy] 3L:
9330982-9338167;9339691-9340742;9341277-9342747 (from sequence
start until end of exon 6, then from beginning of exon 11 until end of exon
13, then from beginning of 39UTR of exon 14 until sequence end). Vectors
with PGRP-LC and PGRP-LF carry the same sequences as described
above but extend until 3L:9345348 instead of 3L:9342747.
Fly genotyping
The following primers were used to genotype flies: PGRP-LCa forward 59-
TGGACAACATTGGTGGTGG-39, reverse 59-GACCAATGAGTCCAGT-
TGGC-39; PGRP-LCx forward 59-GGTGAATGTCGTCCAATCG-39, re-
verse 59-ATTTCGTGTGACCAGTGCG-39; PGRP-LCy forward 59-TTCC-
TGTTCTTATTGGACTCGAG-39, reverse 59-TTGAGTCATATGCAGAT-
CGGG-39; primers to verify the PGRP-LCE12 deletion: forward 59-CACA-
CGCTGCCATATCAGAC-39, reverse 59-TATCGGTTTTCCTGGGTGAG-39
(will amplify a 212-bp fragment from PGRP-LCE12 DNA but not from wild
type); primers to verify the PGRP-LCird7(1) insertion: forward 59-TCAAG-
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TTAACCGGGACCAAC-39, reverse 59-TTTGGCCCATTAAAGCAAAC-39
(will amplify 1331 bp from wild-type and vector DNA, 2189 bp from PGRP-
LCird7(1) DNA, and 2045 bp from vector DNA carrying the eGFP insert).
Bacterial strains and elicitors
All bacteria were grown as shaking cultures in Luria–Bertani medium
overnight: Erwinia carotovora carotovora 15 and Pseudomonas entomo-
phila at 29˚C, Bacillus subtilis at 37˚C. Bacterial strains were used at the
following ODs: Gram-negative DAP-type Erwinia carotovora carotovora
15 at OD600 200, P. entomophila at OD600 200, Gram-positive DAP-type B.
subtilis at OD600 20. Polymeric PGN purified from Escherichia coli and
synthetic monomeric PGN (TCT) were gifts from Dominique Mengin-
Lecreulx (University of Orsay, Orsay, France).
Infection and survival experiments
Throughout this study infections were performed on 2 to 5-day-old adults,
with males for survival and females for mRNA quantification. For systemic
infection with bacteria, flies were pricked in the thorax with a metal needle
dipped in bacterial pellets and shifted to 29˚C for optimal bacterial pro-
liferation. Flies in survival experiments were kept on medium without
fresh yeast and survivors counted daily. Purified elicitors were micro-
injected using a Nanoject apparatus (Drummond) and pulled glass needles.
PGN was injected at a dose of 13.8 nl, 0.05 mg/ml, and TCT at a dose of
13.8 nl, 0.42 mM. For oral infection, flies were starved 2 h at 29˚C then
flipped onto fly medium covered with filter disks soaked in a 1:1 mix of
bacterial pellets and 5% sucrose or TCT at 0.021 mM in 2.5% sucrose and
left to feed for 12–15 h, as previously described (35).
Quantitative RT-PCR
For quantification of Diptericin mRNA, whole flies or dissected intestines
(cardia to Malpighian tubule branching point) were collected at indicated
time points. Total fly RNA was isolated from 5–10 adult flies or 15–20
dissected adult intestines by TRIzol reagent and dissolved in 30 ml (whole
flies) or 10 ml (intestines) of RNase-free water. Five hundred nanograms
total RNA was then reverse-transcribed in 10 ml reaction volume using
Superscript II enzyme (Invitrogen) and random hexamer primers. Quan-
titative PCR was performed on a LightCycler 480 (Roche) in 96-well
plates using the LightCycler 480 SYBR Green I master mix. Primers were
as follows: Diptericin forward 59-GCTGCGCAATCGCTTCTACT-39, re-
verse 59-TGGTGGAGTGGGCTTCATG-39; RpL32 forward 59-GACGC-
TTCAAGGGACAGTATCTG-39, reverse 59-AAACGCGGTTCTGCATG-
AG-39; PGRP-LCx forward 59-TTTGTCCTTTTCTGCCCAAC-39, reverse
59-ATCCAAGTCCGTTTGGTTCA-39; PGRP-LCy forward same as PGRP-
LCx, reverse 59-TCAGGATCATTCGTTTGGTTC-39; PGRP-LCa forward
59- TCTGGACAACATTGGTGGTG-39, reverse 59-TCACACTTCTGCGA-
CGATTC-39.
Immunohistochemistry and confocal microscopy
Fat bodies from [GFP-LC];PGRP-LCird7(1) adult females were dissected
and fixed in 4% paraformaldehyde with 0.1% Tween to permeabilize tis-
sues. Fat bodies were stained with rabbit anti-GFP (Interchim) and Alexa
594-coupled mouse anti-rabbit (Molecular Probes) diluted to 1:500 and
1:2000, respectively, in blocking solution (PBS, 0.1% Tween, 2% BSA),
and nuclei were stained with DAPI. Images were acquired using a Zeiss
LSM700 upright confocal microscope and a 340/1.30 NA oil immersion
objective, with zoom set to 31.6 and z steps of 0.48 mm. For publication
purposes, brightness and contrast were increased identically on control and
sample images.
Statistical analysis
All analyses were performed using GraphPad Prism software version 5.02.
Survival curves were compared using log-rank tests, and where multiple
comparisons were necessary, Bonferroni corrections for p values were
applied. All other data were subjected to appropriate ANOVA with Dun-
nett, Tukey, or Bonferroni post hoc tests.
Results
Generation of flies expressing single PGRP-LC isoforms
The PGRP-LC locus including regulatory regions spans ∼10 kb
between the PGRP-LA and PGRP-LF loci on chromosome 3L
(Fig. 1). Alternative splicing of variable extracellular domain-
encoding exons generates three membrane-bound receptor iso-
forms (PGRP-LCa, PGRP-LCx, and PGRP-LCy) differing in their
PGN recognition domain. To build complementation vectors that
would mimic wild-type PGRP-LC expression when reinserted into
the genome, we cloned a genomic fragment including the 39UTR
of PGRP-LA and all exons and introns of PGRP-LC with or
without PGRP-LF into P[acman] vectors using gap repair and
recombineering techniques (33, 34). These full complementation
vectors contain all necessary elements to give rise to all known
splice isoforms. Single isoform vectors were then generated by
selective deletion of isoform-specific exons as shown in Fig. 1. In
addition, a set of full locus vectors (PGRP-LC with or without
PGRP-LF) was also engineered to contain an eGFP coding se-
quence before the coding sequence of PGRP-LC. All vectors were
inserted by PhiC31 integrase-mediated transgenesis into the
PhiC31 landing site 51C on chromosome 2 (33). Vector-carrying
lines were then combined to two different PGRP-LC null mutants,
FIGURE 1. Genomic organization of the PGRP-LC locus and vector constructs. Genomic organization of the extended PGRP-LC locus is based on
FlyBase release r5.42. Exons VII to XIVencode extracellular PGRP domains. PGRP-LC is preceded by PGRP-LA and followed by PGRP-LF and UGP on
the reverse strand. Full-length complementation vectors [LC,LF] carry gene region 3L:9330982-9345348 including the 39UTR of PGRP-LA, all exons and
introns of PGRP-LC and of PGRP-LF, as well as the two last exons and 39UTR of UGP. Short complementation vectors [LC] carrying gene region
3L:9330982-9342747 are truncated at 239 bp before the start codon of PGPR-LF. Single isoform complementation vectors ([LC] vectors depicted only)
contain the above minus nonspecific exons. Isoform PGRP domains are encoded as follows: PGRP-LCx by exons VIII and IX, PGRP-LCy by exons XII and
XIII, and PGRP-LCa by exons VII and XIV. Additional N-terminal fusion constructs of the full locus with eGFP were generated by inserting the coding
sequence of eGFP (without its start and stop codons) after the start codon in exon 4 in both [LC,LF] and [LC] vectors.
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namely PGRP-LCE12, lacking the whole PGRP-LC locus (25), and
PGRP-LCird7(1), which cannot translate the full PGRP-LC protein
due to an insertion in the first coding exon (24). Assuming inte-
gration does not significantly alter the expression of the transgene,
this should result in full or isoform-specific rescue of the mutation.
We tested this hypothesis by infecting these flies through septic
injury with the Drosophila Gram-negative pathogen Erwinia
carotovora carotovora 15 and monitoring survival (Fig. 2A).
PGRP-LC null mutants generally succumb to infection within 24
to 48 h, whereas wild-type flies survive the infection (24–26).
Both [LC] and [LC,LF] vectors were able to rescue PGRP-LCird7(1)
and PGRP-LCE12 to wild-type levels, although the rescue in
PGRP-LCE12 was slightly less efficient. The additional genomic
copy of PGRP-LF from [LC,LF] vectors did not impact signifi-
cantly on survival. However, the intensity of the immune response
is influenced by the stoichiometry of genomic copies of PGRP-LC
and PGRP-LF. Indeed, increasing the genomic ratios of PGRP-LF
to PGRP-LC correlated with reduced expression of the antimi-
crobial peptide Diptericin (Dpt), one of the downstream targets of
the Imd pathway (Supplemental Fig. 1). This is in agreement with
a role of PGRP-LF as negative regulator of the Imd pathway (15).
We also verified whether the GFP tag on the N-terminal, cy-
toplasmic tail of the receptor would interfere with function. As
shown in Fig. 2B, the presence of GFP does not significantly alter
survival levels. Using the GFP tag, we analyzed PGRP-LC tissue
expression by immunohistochemistry. Remarkably, PGRP-LC was
enriched in the membrane of adult fat body cells facing the
hemocele, consistent with a role in sensing ligands carried in the
hemolymph (Fig. 2C, upper panels). This apico-lateral localiza-
tion of a receptor also indicates that adult fat body cells are po-
larized. The localization of PGRP-LC in the fat body did not
change noticeably upon infection with Erwinia carotovora
carotovora 15 (Fig. 2C, lower panels). Although PGRP-LC is
expressed in other organs such as the gut or the trachea [Ref. 13
and FlyAtlas (36), Supplemental Fig. 2, and real-time quantitative
PCR (RT-qPCR), data not shown), GFP-tagged PGRP-LC in these
tissues was below the detection limits of immunochemistry.
Finally, expression dynamics of single isoforms produced from
the chromosome 2 [LC] transgene were comparable to those from
the wild-type PGRP-LC locus on chromosome 3 (Fig. 2D), sug-
gesting that all major regulatory elements are present in the rescue
vectors.
PGRP-LCx is necessary and sufficient in vivo to mediate Imd
pathway activation during systemic infection
To test the in vivo role of each isoform, single isoform comple-
mentation lines were established on the PGRP-LCE12 background
([LCa/a];PGRP-LCE12 or [LCx/x];PGRP-LCE12). For the com-
plementation with PGRP-LCy, only the extended locus insertion
with PGRP-LF was available, resulting in the [LCy,LF];PGRP-
LCE12 complementation line. These lines were then crossed be-
tween each other to obtain flies expressing a combination of two
distinct isoforms ([LCa/x];PGRP-LCE12 or [LCx/y,LF];PGRP-
LCE12 or [LCa/y,LF];PGRP-LCE12). Correct isoform genotype in
these lines was verified by PCR (data not shown). As shown in
Fig. 3A, the presence of PGRP-LCx alone or in combination with
PGRP-LCa or PGRP-LCy is necessary and sufficient on its own
for survival to septic injury with Erwinia carotovora carotovora
15, whereas neither PGRP-LCa nor PGRP-LCy, alone or in
combination as PGRP-LCa/y, is able to mount a protective re-
sponse. To assess the ability of each isoform to activate the Imd
pathway, Dpt mRNA levels were quantified at 8 h after bacterial
infection with live or heat-killed Erwinia carotovora carotovora
15 or live B. subtilis (Fig. 3B). Combinations with [LCy,LF];
FIGURE 2. In vivo complementation of PGRP-LC mutants. (A) Both
[LC,LF] and [LC] complementation vectors reestablish a wild-type pheno-
type in loss-of-function mutants of PGRP-LC [alleles E12, ird7(1)]. Males
were infected with Erwinia carotovora carotovora 15 by septic injury and
monitored for survival at 29˚C. Results are pooled data from at least three
independent experiments eachwith 20–30males per genotype. Log-rank test
comparing complemented lines to PGRP-LCE12 and PGRP-LCird7(1), re-
spectively: p, 0.0001. (B) The presence of an N-terminal GFP tag does not
interfere significantly with receptor function. Flies were treated as in (A).
Log-rank test comparing lines with and without GFP tag: p = 0.5001. Raw
survival data for (A) and (B) can be found in Supplemental Table I. (C) GFP–
PGRP-LC localizes to the apico-lateralmembrane of adult fat body cells. Fat
bodies from [GFP-LC];PGRP-LCird7(1) adult females (uninfected, upper
panels; 6 h after pricking with Erwinia carotovora carotovora 15, lower
panels) were dissected, fixed, and stained forGFP. PGRP-LC is shown in red,
nuclei are in blue. Shown are top views and orthogonal views from a z-stack
taken through a fat body lobe attached to the cuticle, as shown on the dia-
gram.Arrows indicate the position of top views along the z-axis of apical (z1)
and central (z2) slices. Inset shows background staining on CanS control.
Scale bar in all images, 20 mm. t, trachea. (D) Receptor levels in com-
plemented lines mimic wild-type expression dynamics. Adult females were
left unchallenged (open bars) or systemically infected with Erwinia car-
otovora carotovora 15 for 8 h (hatched bars), and PGRP-LC mRNA levels
were quantified by RT-qPCR.
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PGRP-LCE12 were omitted from this experiment because of the
aforementioned non-negligible effects of PGRP-LC to PGRP-LF
ratios on Dpt mRNA levels. Nevertheless, data discussed later in
this article using [LCy,LF];PGRP-LCE12flies (see Fig. 5) show
that PGRP-LCy alone is unable to confer immune responsiveness.
Again, PGRP-LCx appears necessary and sufficient to activate the
Imd response after sensing DAP-type bacteria (Gram-negative
bacteria or Gram-positive bacilli), whereas PGRP-LCa remains
unable to respond. Notably, the combination of PGRP-LCx and
PGRP-LCa induces a stronger Imd pathway activation than any
other combination of isoforms upon challenge with Gram-negative
bacteria but not B. subtilis. This is consistent with in vitro data
indicating a role of the PGRP-LCa/x heterodimer in sensing the
PGN monomer TCT (6). Given that TCT is released by Gram-
negative bacteria but not DAP-type Gram-positive bacilli such as
B. subtilis, this also suggests a likely explanation as to why the
contribution of PGRP-LCa is observed exclusively in response to
Gram-negative bacteria.
To confirm this hypothesis, we microinjected flies with either
PGN purified from Escherichia coli (composed mostly of poly-
meric PGN) or with a TCT solution. As apparent from Fig. 3C, the
presence of Escherichia coli PGN in the hemolymph is mainly
sensed via PGRP-LCx, whereas TCT induces a very potent and
prolonged response only via the PGRP-LCa/x dimer (Fig. 3D).
Intriguingly, flies carrying the full PGRP-LC locus do not reach
a similar magnitude of response, despite identical expression
levels of PGRP-LC isoforms (Fig. 3E), suggesting that some form
of negative regulation is lacking in PGRP-LCa/x reconstituted
flies. Possibly PGRP-LCy, which is absent from PGRP-LCa/x
reconstituted flies, might dampen the response to TCT in wild-
type flies.
To gain further insight into the possible regulatory role of
PGRP-LCy, we used 3D modeling to determine the likelihood of
PGRP-LCy interacting with PGN. When compared with PGRP-
LCx, PGRP-LCy presents several sequence changes affect-
ing the PGN binding cleft (Fig. 4). The resulting structure is
unlikely to bind PGN, as it exhibits several features described for
PGRP-LCa and PGRP-LFz, two PGRPs that cannot bind to PGN
(19, 22). This analysis suggests that PGRP-LCy is structurally
incapable of binding PGN and exerts its regulatory function
through a mechanism different from that of PGRP-LF.
Collectively, our in vivo studies demonstrate the key role of
PGRP-LCx in sensing DAP-type PGN-containing bacteria. We
also highlight the contribution of PGRP-LCa/x heterodimers to
the systemic immune response to Gram-negative bacteria through
sensing of TCT, whereas PGRP-LCy may have a minor role in
antagonizing the immune response.
PGPR-LE is dispensable for survival to Gram-negative
infections and for systemic sensing of monomeric PGN
The residual level of Dpt upon TCT stimulation in a supposedly
nonresponsive line (PGRP-LCa/a) but not in PGRP-LCE12 (Fig.
3D) indicates an additional sensing mechanism upstream of
PGRP-LC. Previous studies have demonstrated a contribution of
PGRP-LE in the sensing of Gram-negative bacteria, acting in
cooperation with PGRP-LC (28, 29). In particular, secreted or
intracellular forms of PGRP-LE were shown to contribute to TCT
sensing upstream of or in parallel to PGRP-LC. If PGRP-LE
played a substantial role in the systemic protection against
Gram-negative infection, then complementation with PGRP-LC
isoforms on a PGRP-LE112;;PGRP-LCE12 double mutant back-
ground should be less efficient than in single PGRP-LCE12
mutants. However, when comparing the survival capacity of iso-
form complementation lines between single and double mutant
backgrounds, no significant difference was apparent (Fig. 5A and
Supplemental Fig. 3), although there seemed to be a trend toward
slightly diminished survival in complemented PGRP-LE112;;
PGRP-LCE12 mutants. However, results should be evaluated with
caution, as PGRP-LCE12 complemented lines are on a w back-
ground, whereas PGRP-LE112;;PGRP-LCE12 complemented lines
are y,w. Similarly, we observed no difference in Dpt induction
FIGURE 3. PGRP-LCx is necessary and sufficient to respond to Gram-
negative bacteria. (A) Survival analysis to systemic challenge with Gram-
negative bacteria. Males were infected with Erwinia carotovora car-
otovora 15 by septic injury and monitored for survival at 29˚C. Twenty to
thirty males were infected per experiment, and experiments were repeated
at least three times. Log-rank test, Bonferroni corrected threshold for
multiple comparisons: PGRP-LCE12 complemented with [LC], [LCx],
[LCa/x], or [LCx/y,LF] significantly different (p , 0.0001) from PGRP-
LCE12. PGRP-LCE12 complemented with [LCa], [LCy,LF], [LCa/y,LF] not
significantly different (p . 0.05) from PGRP-LCE12. Raw survival data
can be found in Supplemental Table I. (B) Dpt expression in response to
systemic challenge with DAP-type Gram-negative and Gram-positive
bacteria. Females were infected with live Erwinia carotovora carotovora
15 (Ecc15) or heat-killed Erwinia carotovora carotovora 15 (hk Ecc15)
(OD600 200) or live B. subtilis (OD600 25) by septic injury and collected at
indicated time points for mRNA quantification by RT-qPCR. Data repre-
sent the mean + SEM from 10 females per genotype from at least three
experiments. For each type of infection, each genotype was compared with
the respective PGRP-LCE12 infected control using one-way ANOVA with
Dunnett post hoc test. (C and D) Dpt expression in response to injected
polymeric PGN (C) and monomeric PGN [TCT (D)]. Females were
microinjected with Escherichia coli PGN (13.8 nl, 0.05 mg/ml) or syn-
thetic anhydro-monomeric PGN (TCT, 13.8 nl, 0.42 mM) and collected at
indicated time points for mRNA quantification by RT-qPCR (8 h, left y-
axis; 24 h, right y-axis). Results are shown as in (B), and comparisons are
as in (B) to injected PGRP-LCE12 control. (E) mRNA levels of all PGRP-
LC isoforms in unchallenged flies used in (B–D). *0.01 , p , 0.05,
**0.001 , p , 0.01, ***p , 0.001. ns, Not significant, p . 0.05.
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FIGURE 4. Three-dimensionalmodel of the PGRPdomain of PGRP-LCy suggests lack of PGNbinding ability. (A)Alignment ofDrosophilaPGRPdomains
of known structure. Amino acids critical for binding to TCT in PGRP-LCx are highlighted above the sequence in the color code described later in this caption.
(B) The 3Dmodel of the PGRP domain of LCywas calculated with theModeler program (46) using seven homologous structures found by the server HH-pred
(47).The position of TCT (stick mode, cyan) at the molecular surface of PGRP-LCy (gray) derives from superimposing the structure of PGRP-LCx in complex
with TCT (PDB 2F2L) with the model obtained for LCy. Residues of the PGN binding site that are conserved or interact similarly between LCy and LCx are
colored in green. The key residue Tyr399 (LCx numbering is used throughout) is conserved in LCy but oriented differently due to the Ser433 to Thr change in
LCy (orange).Residues that differ betweenLCyandLCxand that create strong clasheswith theTCTare colored in red (His365Glu,Ala367Pro,Ala420Asp, and
Ser481Met). In the structure of LCx in complexwith TCT (20), the imidazole group of His365 contacts the carbonyl group of 2-acetamide and the equatorial 3-
OH of GlcNAc. His365 is strictly conserved in all the PGRPs of known structure except in LCa. In LCy, His365 is replaced by Glu, which cannot play a similar
role due to its negative charge. The presence of Met instead of Ser481 creates strong clashes. This position is always occupied by a serine in PGRPs devoid of
amidase activity (except LCa,which has a phenylalanine at this position) and by a cysteine that coordinates the zinc ion in PGRPswith amidase activity. Asp420
in LCy bonds Arg413 and blocks access to this arginine, which engages in an electrostatic interaction with TCT that is essential for an efficient interaction
between LCx and TCT (20). Asp420 plays a role similar to that described for Gln143 in LFz (22). Finally, two Asn residues (N393 and N428; blue) create
putative glycosylation sites in the vicinity of the binding crevice that may greatly impair access of PGN.
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after challenge with live Erwinia carotovora carotovora 15 when
comparing single or combined isoforms on PGRP-LE112;;PGRP-
LCE12 and PGRP-LCE12 backgrounds (Fig. 5B), confirming pre-
vious results that PGRP-LE is dispensable in vivo for Imd acti-
vation upon systemic infection with Gram-negative bacteria (28).
When flies were injected with TCT, PGRP-LCE12 mutants in-
variably retained a very low capacity to induce Imd signaling,
more marked when complemented with unresponsive PGRP-LC
isoforms, indicating a role of PGRP-LE to sense TCT (Fig. 5C).
In the double PGRP-LE112;;PGRP-LCE12 mutants, TCT respon-
siveness was lost entirely, in agreement with a previous study (29).
Notably, use of complemented PGRP-LE112;;PGRP-LCE12 mutants
demonstrates that detection of TCT now relied exclusively on the
combined presence of PGRP-LCa/x.
Taken together, these results stress the self-sufficiency of PGRP-
LC in combating Gram-negative infection. They also demonstrate
that TCT sensing by the fat body can be mediated either by the
PGRP-LCa/x heterodimer or by PGRP-LE, but that the contribu-
tion of PGRP-LCa/x to TCT sensing prevails over that of PGRP-
LE, likely due to the fact that soluble PGRP-LE partially signals via
membrane-bound PGRP-LC (29). The observation that PGRP-
LE112;[LCx];PGRP-LCE12 flies, which are unable to recognize
TCT due to the lack of both PGRP-LE and PGRP-LCa, still retain
some resistance to infection with Erwinia carotovora carotovora
15 indicates that Erwinia carotovora carotovora 15 is detected
mostly through polymeric PGN.
Both PGRP-LC and PGRP-LE contribute to local Imd
activation in the gut
It has been suggested previously that PGRP-LE engages different
mechanisms of signal transduction depending on its localization:
intracellular, full-length PGRP-LE can signal independently in
response to intracellular ligands, whereas extracellular or secreted
PGRP-LE is signaling-deficient and acts as a soluble coreceptor of
PGRP-LC, reminiscent of CD14 and TLR4 (29). Moreover, dif-
ferent tissues may have different tolerance thresholds to infection:
whereas the hemocele would need to remain strictly sterile, organs
such as the digestive tract or trachea, which are in direct contact
with the external environment, might tolerate higher loads of
bacterial elicitors and keep a tighter control on immune activation.
This prompted us to investigate the role of PGRP-LC isoforms
and PGPP-LE in the intestinal immune response. PGRP-LC and
PGRP-LE are differentially expressed in the fat body and gut
compartments (Supplemental Fig. 2). PGRP-LE is strongly
enriched in the midgut, which is of endodermal origin (depicted as
dashed lines in Fig. 6A), whereas PGRP-LC is slightly enriched in
both the hindgut and the foregut (comprising the crop and the first
half of the cardia), which are of ectodermal origin (depicted as
solid lines in Fig. 6A) [Fig. 6A, 6B; FlyAtlas (36)]. We have
previously shown that PGRP-LC contributes to the gut response
through sensing of PGN, whereas the role of PGRP-LE was not
assessed (9, 37). In particular, Zaidman-Re´my et al. (9) found that
ingestion of Gram-negative PGN or Erwinia carotovora car-
otovora 15 induced PGRP-LC–dependent Dpt expression in the
cardia. This intestinal Imd activation is kept in check by amidase
PGRPs, especially PGRP-LB, which degrades PGN (9, 30). We
therefore wanted to dissect the contribution of PGRP-LC isoforms
and PGRP-LE to the gut immune response. To this end, flies were
orally infected with Erwinia carotovora carotovora 15, which is
nonlethal in this type of infection, and the Dpt response was
quantified in dissected intestinal tissues comprising the cardia and
midgut without Malpighian tubules. As observed for the systemic
immune response in adults, the local Imd pathway activation in
the gut seems to rely on PGRP-LCx (Fig. 6C), albeit without
reaching significance. Along with the residual levels of activation
in PGRP-LCE12 flies, this suggests that another PRR, most likely
PGRP-LE, contributes significantly to the gut immune response.
We therefore reevaluated the local immune response to Erwinia
carotovora carotovora 15 exclusively in the endodermal section
of the gut (midgut without cardia) where the relative enrichment
of PGRP-LE over PGRP-LC suggests a sizeable contribution
of PGRP-LE. PGRP-LE112 mutants are on a y,w background,
which generally reacts stronger to immune stimuli. Therefore,
PGRP-LCE12 and PGRP-LE112 single mutants cannot be com-
pared directly. However, when normalized to their respective ge-
netic background controls, both PGRP-LCE12 and PGRP-LE112
single mutants showed a significant, around 50% contribution to Imd
pathway activation in the midgut (Fig. 6D), and only the combined
FIGURE 5. PGPR-LE is dispensable for survival to Gram-negative
infections and for systemic sensing of monomeric PGN. (A) Sur-
vival analysis to systemic challenge with Gram-negative bacteria in
w;;PGRP-LCE12 or y,w,PGRP-LE112;;PGRP-LCE12 backgrounds com-
plemented with [LC,LF] vectors (LF is omitted from legend for clarity).
Males were infected with Erwinia carotovora carotovora 15 by septic
injury and monitored for survival at 29˚C. Results are shown as mean +
SEM of median survival from at least three independent experiments
each with 20–30 males per genotype. Log-rank test, Bonferroni cor-
rected threshold for multiple comparisons: no significant difference
between single or combined isoforms in PGRP-LCE12 versus PGRP-
LE112;;PGRP-LCE12 backgrounds. Raw survival data can be found in
Supplemental Table I. (B) Dpt expression in response to systemic in-
fection with Erwinia carotovora carotovora 15. Females were infected
with Erwinia carotovora carotovora 15 by septic injury and collected at
8 h for mRNA quantification by RT-qPCR. (C) Dpt expression in re-
sponse to injection of TCT. Females were injected with TCT (13.8 nl,
0.42 mM) and collected at 24 h for mRNA quantification by RT-qPCR.
Results in (B) and (C) represent the mean + SEM from 10 females per
genotype from three independent experiments. Two-way ANOVA with
Bonferroni post hoc tests comparing single or combined isoforms
shows no significant difference between PGRP-LCE12 and PGRP-LE112;;
PGRP-LCE12 backgrounds.
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loss of both receptors completely abolished the midgut response
to infection. This clearly indicates that PGRP-LC and PGRP-LE
contribute equally to the activation of the Imd pathway by
Gram-negative bacteria in the midgut.
Sensing of TCT in the gut
We next wanted to address whether TCT is directly detected in the
gut and to what extent each receptor contributes to this detection.
PGRP-LE has been implicated in the sensing of TCT in absorptive
tissues like the Malpighian tubules (29), but its role in the intestinal
epithelium remains untested. In a preliminary set of experiments,
we were unable to detect any strong activation of the Imd pathway
upon oral ingestion of TCT. As mentioned above, PGRP-LB
rapidly hydrolyzes free intestinal PGN (9, 30), raising the hy-
pothesis that ingested TCT was immediately degraded prior to
detection by gut PRRs. To detect a local epithelial response to
ingested TCT, we analyzed the contribution of PGRP-LC or
PGRP-LE in PGRP-LBD mutant flies. Notably, the response to
TCT in intestinal tissues (midgut with cardia) was only slightly
affected by the loss of PGRP-LC alone, more so by the loss of
PGRP-LE alone, and was completely abolished in mutants lacking
both PGRP-LC and PGRP-LE (Fig. 6E). Note that complemented
PGRP-LE112;[LC,LF];PGRP-LBD,PGRP-LCE12 flies were used
as a surrogate for PGRP-LE112;;PGRP-LBD single mutant flies
because of the poor growth of PGRP-LE112;;PGRP-LBD stocks.
From this experiment, we conclude that intestinal cells have the
capacity to detect TCT prevalently through PGRP-LE, with a
smaller contribution of PGRP-LC.
Long-range activation of immune responses to Gram-negative
bacteria relies on PGRP-LCa/x dimers
A subset of Gram-negative bacteria, including P. entomophila, is
lethal to Drosophila even when given by oral route and results in
both local and systemic immune responses (38, 39). The fat body
response to gut bacteria is thought to be caused by active or
passive translocation of bacterial products through the gut barrier,
loss of epithelial integrity, or escape of bacteria from the gut.
PGRP-LB is proposed to play a major role in preventing this
ectopic response by digesting intestinal PGN, a hypothesis sup-
ported by loss of tolerance to nonvirulent gut bacteria in PGRP-LB
knockdown flies (9). We have proposed but not formally demon-
strated that small PGN fragments, especially TCT, act as diffusible
signaling molecules from the gut to elicit a systemic immune
response in PGRP-LB knockdown or mutant flies (8, 9). There-
fore, we tested which PGRP-LC isoforms were required for long-
range activation of Imd both in the response to lethal P. entomo-
phila as well as in PGRP-LBD mutant flies fed nonlethal Erwinia
carotovora carotovora 15.
Oral infection with Erwinia carotovora carotovora 15 in PGRP-
LC isoform-complemented PGRP-LBD mutant flies generated
a systemic response that was mainly mediated through PGRP-
LCa/x dimers (Fig. 7A). Taking into consideration that TCT is
the only ligand sensed by the PGRP-LCa/x heterodimer, our result
indicates that this response is mediated by TCT sensing. To verify
that TCT is indeed the long-distance elicitor generating this phe-
notype, we directly fed TCT to these flies and observed the same
pattern of PGRP-LC isoform dependence (Fig. 7B). In this case,
the high background levels of TCT responsiveness even in the
complete absence of PGRP-LC were reminiscent of our results
with systemic injection of TCT (compare with Fig. 3D). There-
fore, we also tested the relative contribution of PGRP-LE and
PGRP-LC in the systemic response of PGRP-LBD mutant flies to
oral infection with Erwinia carotovora carotovora 15. Fig. 7C
shows that both PGRP-LE and PGRP-LC significantly contribute
to systemic activation of the Imd pathway by TCT feeding of
PGRP-LBD–deficient flies.
Likewise, when wild-type flies were orally infected with lethal P.
entomophila, the ensuing systemic immune response relied mainly
on the PGRP-LCa/x combination (Fig. 7D), indicating that this
response is mediated by TCT. The observation that wild-type flies
or PGRP-LCE12 mutants carrying the full PGRP-LC locus do not
reach the same amplitude of response compared with PGRP-LCa/x
reconstituted flies (Fig. 7B, 7D) is puzzling. A possible expla-
FIGURE 6. Local responses to oral infection rely on combined action of
PGRP-LC and PGRP-LE. (A) Adult Drosophila digestive system, com-
prising crop, cardia, midgut, Malpighian tubules (M. tub., truncated), and
hindgut (truncated). Solid line, ectodermal origin; dashed line, endodermal
origin. Full bars indicate dissection points for experiments using midgut
with cardia (mixed endodermal and ectodermal tissue); hatched bar indi-
cates dissection point for experiments using exclusively endodermal
midgut tissue. (B) Expression levels of different PGRP genes based on
FlyAtlas. (C) Intestinal Dpt expression in response to oral challenge with
a nonlethal Gram-negative pathogen. Females were fed a mix of sucrose/
Erwinia carotovora carotovora 15 for 12–15 h, after which intestines were
collected for mRNA quantification by RT-qPCR. Results represent the
mean + SEM from 15–20 females per genotype from three independent
experiments. All genotypes were compared with PGRP-LCE12 using one-
way ANOVA with Dunnett post hoc test; no significant difference was
observed. (D) Both PGRP-LC and PGRP-LE contribute to intestinal Dpt
expression in response to Erwinia carotovora carotovora 15. Females were
treated as in (B) but intestines were dissected to include only tissues of
endodermal origin. Results represent the mean + SEM from 20–25 females
per genotype from three independent experiments expressed as Dpt/RpL32
ratios. Note different y-axis scales: the immune response in y,w flies is
three times stronger than in CanS. One-way ANOVA with Tukey post hoc
test was performed separately for each background. (E) The intestinal
response to TCT relies on PGRP-LE and PGRP-LC. Females of indicated
genotypes were fed a mix of sucrose/TCT (0.02 mM) for 12–15 h, after
which intestines were collected for mRNA quantification by RT-qPCR.
Results are shown as described in (C). All genotypes were compared
pairwise using one-way ANOVA with Tukey post hoc test. *0.01 , p ,
0.05, **0.001 , p , 0.01, ***p , 0.001. ns, Not significant, p . 0.05.
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nation brought forward before is that PGRP-LCy, which is absent
from PGRP-LCa/x reconstituted flies, might dampen the response
to TCT in wild-type flies. As apparent from Fig. 7E, loss of
PGRP-LE had no significant effect on the systemic response to P.
entomophila. However, the levels of systemic Dpt induction in the
P. entomophila model are five times lower than those observed in
the TCT-fed PGRP-LBD mutant model (compare non-normalized
Dpt/RpL32 ratios in Fig. 7C and 7E), a situation that might mask
the possible contribution of PGRP-LE.
Taken together, these experiments prove that long-range acti-
vation of the systemic response upon oral infection is mediated by
TCT and that the PGRP-LCa/x heterodimer plays a major role in
sensing TCT. However, we noted a discernible role of PGRP-LE in
eliciting systemic responses to orally administered TCT in PGRP-
LBD mutants.
Discussion
Our initial aim was to define the role of each PGRP-LC isoform
in vivo. Using Phi31-mediated recombineering, we successfully
inserted loci of full and isoform-specific PGRP-LC constructs into
the fly genome and proved they were capable of complementing
PGRP-LC null mutations. Our in vivo approach confirms and
extends previous in vitro and RNAi experiments in proving that
PGRP-LCx is indeed necessary and sufficient to respond to
challenge with live or dead Gram-negative bacteria and to Gram-
positive, DAP-type bacilli. Moreover, PGRP-LCx alone induces
the in vivo immune response to polymeric PGN, whereas com-
bined presence of PGRP-LCx and PGRP-LCa is necessary to
sense the anhydro-monomer TCT. The differential requirement
of PGRP-LC isoforms in response to Gram-positive DAP-type
(PGRP-LCx alone) and Gram-negative bacteria (both PGRP-LCx
and PGRP-LCa/x) indicates that flies are able to discriminate
between the two types of DAP-type PGN-containing bacteria and
to mount appropriate responses. Notably, injection of TCT in
contrast to polymeric PGN leads to an increase in amplitude and
duration of Imd pathway activation (Ref. 9 and this study). Thus,
TCT detection by PGRP-LCa/x allows flies to mount a strong
response to Gram-negative bacteria despite the fact that DAP-type
FIGURE 7. Long-range activation of immune response to Gram-negative bacteria relies on TCT recognition by PGRP-LCa/x dimers and PGRP-LE. (A and
B) Loss of systemic tolerance to oral infection with a nonlethal Gram-negative pathogen in PGRP-LBD,PGRP-LCE12 backgrounds complemented with [LC,LF]
vectors (LF omitted in legend for clarity). Females were fed Erwinia carotovora carotovora 15 (A) or synthetic TCT (B) for 12 h, then whole flies were
collected for mRNA quantification by RT-qPCR. Results are shown as mean + SEM from 10 females per genotype from at least three independent experiments.
All genotypes were compared with PGRP-LCE12 using one-way ANOVA with Dunnett post hoc test. All genotypes were compared with PGRP-LCE12 using
two-way ANOVAwith Bonferroni post hoc test. (C) PGRP-LE contributes to the systemic response to oral infection in PGRP-LBD-deficient flies. Females were
fed a mix of sucrose/ Erwinia carotovora carotovora 15 for 12–15 h, after which whole flies were collected for mRNA quantification by RT-qPCR. Data
represents the mean + SEM from 10 females per genotype from at least three independent experiments. One-way ANOVA with Tukey post hoc test was
performed separately for each background. (D) Systemic Dpt expression in response to oral challenge with a lethal Gram-negative pathogen. Females were fed
sucrose/P. entomophila for 12 h, after which whole flies were collected for mRNA quantification by RT-qPCR. Results are shown as in (A). (E) Experiments in
(D) were repeated with mutants for either PGRP-LE or PGRP-LC and their respective background controls. Results represent the mean + SEM from 20–25
females per genotype from at least three independent experiments, expressed as Dpt/RpL32 ratios. Note the stronger immune response in y,w flies. Results were
analyzed using one-way ANOVA with Tukey post hoc test. *0.01 , p , 0.05, **0.001 , p , 0.01, ***p , 0.001. ns, Not significant, p . 0.05.
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PGN is not exposed (masked by the LPS layer) and is less
abundant compared with DAP-type PGN-containing Gram-posi-
tive bacteria (40).
Consistent with previous reports that showed no effect of PGRP-
LCy RNAi on PGN sensing in cells (6, 14), PGRP-LCy on its own
did not show any induction of the Imd pathway. However, bac-
terial infection or injection of immunostimulatory compounds
repeatedly produced a stronger response in flies carrying PGRP-
LCa/x isoforms than in flies carrying the whole PGRP-LC locus.
Although we cannot exclude subtle differences in isoform ex-
pression from the intact, full locus compared with the engineered
isoform loci, this suggests that the full locus carries an additional
regulatory element lacking in heterozygous PGRP-LCa/x flies. It
is tempting to speculate that PGRP-LCy, present in the full locus
but absent from PGRP-LCa/x flies, might help to regulate re-
sponse levels. PGRP-LCy is structurally unlikely to bind PGN but,
unlike PGRP-LF, retains a signaling-competent cytoplasmic tail.
If any regulatory activity was associated with the PGRP-LCy
isoform, it would therefore have to act extracellularly, possibly
by competing with other isoforms for cell surface localization and
thereby diluting receptor availability. Thus, the only function we
can attribute to PGRP-LCy from this study is a regulatory role in
adjusting the amplitude of Imd pathway activation.
The importance of wild-type receptor levels in any study of
isoform function is crucial because overexpression of receptors is
sufficient on its own to stimulate the Imd pathway (24, 25). Our
PGRP-LC complemented system mimics wild-type receptor ex-
pression dynamics, and we did not detect any elevated background
levels of Imd activation in complemented PGRP-LC mutant flies
(data not shown). However, alterations in the genomic ratio of
PGRP-LC to PGRP-LF, achieved by combining [LC] or [LC,LF]
vector-carrying lines with wild-type or different PGRP-LC–defi-
cient backgrounds, showed a significant correlation between Dpt
levels and PGRP-LC/LF ratios in infected flies, consistent with an
inhibitory role of PGRP-LF (15, 16). This indicates that the
stoichiometry of activating and regulating receptors matters, as
foreshadowed by affinity studies between signaling-competent
PGRP-LCx–TCT–PGRP-LCa and signaling-deficient PGRP-
LCx–TCT–PGRP-LF complexes (22).
Several overexpression studies in S2 cells already localized
PGRP-LC to the plasma membrane (6, 41). We extend this finding
to wild-type receptor expression levels in an immunocompetent
tissue and provide evidence that PGRP-LC localizes to the apical
and lateral plasma membrane in fat body cells, revealing a previ-
ously undescribed polarity in this immune-responsive tissue.
Similar to Takehana et al. (28), who described no significant
difference betweenDpt expression in PGRP-LC versus PGRP-LE;;
PGRP-LCmutants after stimulationwithB. subtilis andEscherichia
coli, we see no additional decrease in survival rates to Erwinia
carotovora carotovora 15 when comparing single PGRP-LC and
double PGRP-LE;;LC mutants, and no significant underlying
reduction inDpt levels. This underlines the major role of PGRP-LC
to survey a defined compartment—the insect hemolymph—and to
preferentially activate immune responses in the fat body.
In general agreement with Kaneko et al. (29), we confirmed
a role of PGRP-LE in the systemic immune response to TCT,
albeit depending on the route of administration. On one hand, we
note a predominant role of PGRP-LCa/x over PGRP-LE in sens-
ing injected TCT in the hemolymph. In this context, the contri-
bution of PGRP-LE was discernible in the presence of any PGRP-
LC isoform but was less marked in the absence of the full locus,
consistent with the concept that hemolymph PGRP-LE cannot
signal directly but depends on membrane-bound PGRP-LC to
relay information (29). However, even though secreted PGRP-LE
might contribute to Imd activation by delivering hemolymph TCT/
PGN to membrane-bound PGRP-LC, the effect of complete
PGRP-LE loss on systemic immune activation after injection of
TCT into the hemocele was not significant. This suggests that the
cytosolic, autonomous PGRP-LE form does not contribute sig-
nificantly to the activation of the Imd pathway by injected TCT
and establishes PGRP-LC as the predominant receptor eliciting
systemic responses in the hemocele.
On the other hand, when Imd activation in the fat body was
triggered by oral ingestion of TCT in the PGRP-LB mutant
background, we observed a non-negligible contribution of PGRP-
LE to this systemic response in the absence of PGRP-LC. This
indicates that when TCT reached the hemocele by active or passive
transport from the intestine, the role of cytosolic PGRP-LE became
more prominent. Although we have no explanation for this dis-
crepancy, one might speculate that even though cytosolic PGRP-
LE does not significantly contribute to TCT sensing when injected
into the hemolymph, possibly because the fat body lacks trans-
porters present in absorptive organs, this intracellular mode of
recognition gains in importance when TCT transits through cells.
Taken together, the subordinate role of secreted PGRP-LE
compared with PGRP-LC might suggest that the main contribu-
tion of PGRP-LE is as an intracellular sensor, which will only
spring into action when systemic levels of TCT have reached a
critical threshold and permeated the cytosol.
Determining the mechanisms by which barrier epithelia sense
bacteria and differentiate between acceptable and nonacceptable
intruders is a major issue in the field of innate immunity. Previous
studies proposed PRR compartmentalization as an essential mech-
anism to discriminate between pathogenic versus beneficial bac-
terial colonization (42). Although we observed a clear role of
PGRP-LC sensing in the gut, consistent with previous studies, we
cannot conclude whether this reflects direct sampling of the gut
lumen by PGRP-LC. Unfortunately, the expression of the PGRP-
LC-GFP fusion construct was not strong enough to determine
whether PGRP-LC is expressed at the apical or the basal side of
enterocytes. Of note, recognition PGRPs involved in the sensing
of Gram-negative bacteria show differential expression patterns
along the gut, with enrichment of PGRP-LE in the endodermally
derived midgut and a modest enrichment of PGRP-LC in ecto-
dermally derived foregut and hindgut. Moreover, PGRPs in these
sections are more or less accessible to gut contents. A relatively
impermeable cuticle protects ectodermal epithelia in the foregut
and hindgut, whereas the peritrophic matrix covering the PGRP-
LE-rich section of the midgut is permeable to allow passage of
digested nutrients (43). It is therefore more likely for bacterial
compounds to reach midgut epithelia, and a reduction in surface
receptors capable of mounting potentially detrimental immune
responses to commensals in this compartment would make sense.
Cytosolic receptors expressed in this compartment would be able
specifically to detect absorbed or diffusible bacterial compounds
such as TCT, which may be a hallmark of proliferation and/or
harmful bacteria. Consistent with this, we saw a major contribu-
tion of PGRP-LE (most probably of the cytosolic form as PGRP-
LE signaling did not depend on PGRP-LC) and less of PGRP-LC
when we assessed the midgut-specific response to Gram-negative
bacteria. More strikingly, the midgut response to ingested TCT
relied mostly on PGRP-LE, supporting a role of this receptor in
danger detection in the gut. Thus, our study uncovers a key role of
PGRP-LE in the Drosophila midgut and suggests that intracellular
sensing of TCT is used in Drosophila as a mechanism to recognize
infectious bacteria.
We previously put forward a model whereby long-range acti-
vation of the systemic immune response in Drosophila is mediated
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by the translocation of small PGN fragments from the gut lumen
or other barrier epithelia to the hemolymph. This view was sup-
ported by the observation that ingestion of monomeric PGN can
stimulate a strong systemic immune response in PGRP-LB
knockdown flies with reduced amidase activity and that deposition
of PGN or TCT on the genitalia is sufficient to induce a systemic
immune response (8, 9). Moreover, because TCT consistently
elicited stronger responses than PGN, these models proposed an
involvement of active or passive transport of the elicitor to the
hemocele. On the basis of our results, we cannot yet conclude the
mechanism of TCT delivery to the hemocele. However, the unique
and well-characterized interaction of TCT–PGRP-LCa–PGRP-
LCx (20) and the primordial role of PGRP-LCa/x heterodimers
in mediating TCT-specific systemic activation of the Imd pathway
(this study) demonstrates that TCT is indeed a crucial element in
the long-range activation of the immune response.
In conclusion, our study shows that a combination of extra-
cellular sensing by PGRP-LC isoforms and intracellular sensing
through PGRP-LE provides sophisticated mechanisms to detect
and differentiate between infections by different DAP-type bacteria
in Drosophila. It is probable that the absence of LPS sensing in
Drosophila has imposed some constraints on the system and that
sensing of TCT through PGRP-LCa/x and PGRP-LE evolved as
a surrogate way to distinguish Gram-negative bacteria from Gram-
positive DAP-type PGN-containing bacteria. Because TCT is re-
leased during bacterial division, intracellular sensing through
PGRP-LE provides an adequate mechanism of detection in the
gut, reminiscent of the intracellular sensing of Gram-negative
muropeptides by intracellular NOD1 in epithelia (44, 45). To date,
the existence of a mode of recognition of lysine-type bacteria in the
midgut remains unexplored. A simple explanation could be that
lysine-type bacteria do not represent a threat for flies as they rarely
infect via the oral route and are therefore not detected. Indeed,
DAP-type PGN-containing bacteria of either Gram-negative
type (Serratia, Pseudomonas) or bacillus-type (Bacillus thur-
ingiensis) are the only characterized naturally occurring insect
pathogens to date.
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